REQUEST A DEMO
Total
USD $0.00
Search more companies

Dch Auriga (Singapore) Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Wholesale Trade
Full name: Dch Auriga (Singapore) Pte. Ltd. Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: wholesale trade of a variety of goods without a dominant product (marketing, warehousing and distribution of consumer and healthcare products)

Headquarters
10 Raeburn Park, #01-33, Singapore
Singapore; Singapore; Postal Code: 088702

Contact Details: Purchase the Dch Auriga (Singapore) Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Dch Auriga (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Dch Auriga (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
December 05, 1979
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dch Auriga (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
92.57%
Total operating revenue
92.57%
Net Profit (Loss) for the Period
609.17%
Total assets
-18.75%
Total equity
88.65%
Net Profit Margin
1.71%
Return on Equity (ROE)
-768.92%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?